You are here: Industry Insights > Takeda

News List

EC approves Alofisel for complex perianal fistulae in Crohn’s disease europeanpharmaceuticalreview
April 04, 2018
The EC has approved Alofisel for the treatment of complex perianal fistulae in adult patients with nonactive/mildly active luminal Crohn’s disease…
Rhythm Pharma in-licenses PWS candidate from Takeda biospectrumasia
April 04, 2018
Takeda will receive an upfront payment of $5M of Rhythm common stock, back-end development milestones and single-digit royalties on net sales.
Analysts Question Takeda-Shire Deal, Speculate on Bidding War biospace
March 30, 2018
Yesterday’s news that Japanese company Takeda Pharmaceuticals was consideringacquiring UK-based Shire is raising the possibility of a bidding war
The Big Tease: Takeda Considers Buying Shire biospace
March 29, 2018
Shire stock prices jumped up to 26 percent on rumors that Takeda Pharmaceuticals was considering a buyout.
Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal Phase 2 PACE Trial in Blood biospace
March 23, 2018
Takeda Pharmaceutical Co., Ltd. announced today that it has published in the blood about refractory chronic myelogenous leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia.
Denali Therapeutics Adds $155 Million from Takeda biospace
March 20, 2018
Denali Therapeutics Inc., located in South San Francisco, California, had a lot of news to share today.
Takeda to build new facility in Dublin creating 70 new jobs biospectrumasia
March 06, 2018
The company plans to construct a modular cell therapy facility dedicated to manufacturing a novel stem cell therapy
Roche and Takeda use Organs-On-Chip technology for R&D biospectrumasia
March 05, 2018
Roche and Takeda will be using organ-chip technology in their R&D by partnering with Emulate, the biotech startup behind organs-on-a-chip
Takeda to add 70 jobs with €25m Dublin investment pharmafile
March 02, 2018
Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a novel stem cell therapy” at Grange Castle in Dublin will create up to 70 new jobs in the process.
Zika vaccine candidate granted FDA fast track designation europeanpharmaceuticalreview
January 31, 2018
The FDA has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page